Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid in Asymptomatic/Early Stage Multiple Myeloma
NCT00216151Phase 2Terminated
- Sponsor
- Hoosier Cancer Research Network
- Start
- Jun 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in multiple myeloma (MM), sponsored by Hoosier Cancer Research Network. Started Jun 2005; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00216151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216151.